Defective TGF-beta signaling sensitizes human cancer cells to rapamycin (Q40093525)

17 September 2017

title

Defective TGF-beta signaling sensitizes human cancer cells to rapamycin (English)

1 reference

17 September 2017

Gadir N

1

1 reference

17 September 2017

Jackson DN

series ordinal

2

1 reference

17 September 2017

Lee E

series ordinal

3

1 reference

17 September 2017

Foster DA

series ordinal

4

1 reference

17 September 2017

language of work or name

English

0 references

publication date

13 August 2007

1 reference

17 September 2017

1 reference

17 September 2017

volume

27

1 reference

17 September 2017

issue

8

1 reference

17 September 2017

page(s)

1055-1062

1 reference

The IGF‐1 receptor in cancer biology

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Alternative phospholipase D/mTOR survival signal in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Phospholipase D confers rapamycin resistance in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Targeting mTOR-mediated survival signals in anticancer therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Targeting Phospholipase D-mediated Survival Signals in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Regulation of mTOR by phosphatidic acid?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

An expanding role for mTOR in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

The enigmatic protein kinase Cdelta: complex roles in cell proliferation and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Suppression of cell migration by protein kinase Cdelta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

21 January 2018

Focus on pancreas cancer

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Tumor promotion by depleting cells of protein kinase C delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Targeting the PI3K-Akt pathway in human cancer: rationale and promise

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Role of Smad4 (DPC4) inactivation in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Transforming growth factor-beta 1 regulates Kir2.3 inward rectifier K channels via phospholipase C and protein kinase C-delta in reactive astrocytes from adult rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten /- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Smad3 and PKCdelta mediate TGF-beta1-induced collagen I expression in human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Will mTOR inhibitors make it as cancer drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

TOR, a central controller of cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Mammalian target of rapamycin and 3-phosphatidylinositol 3-kinase pathway inhibition enhances growth inhibition of transforming growth factor-beta1 in prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Phospholipase D prevents apoptosis in v-Src-transformed rat fibroblasts and MDA-MB-231 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

Rapamycin induces Smad activity in prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1210721

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1210721

1 reference

Dimensions Publication ID

17 September 2017

1042816782

0 references

1 reference